Financings
Algernon Health closes second tranche of financing

AGN · Price
Executive Summary
- Algernon Health Inc. has closed the second tranche of its non-brokered private placement, raising $210,000.
- The tranche consisted of the sale of 3 million units at a price of $0.07 per unit.
- Proceeds are designated for advancing the Alzheimer's disease program, opening the first U.S. AD clinic, general and administrative expenses, and working capital.
Key Details
- Transaction Structure: Non-brokered private placement.
- Gross Proceeds: $210,000.
- Units Sold: 3,000,000 units.
- Issue Price: $0.07 per unit.
- Finders' Fees: No cash finders' fees were paid for this tranche.
- Use of Proceeds: Advancing Alzheimer's disease (AD) program, opening the first U.S. AD clinic, general and administrative expenses, and working capital.
- Securities Terms: Securities are subject to a statutory hold period of four months plus one day from the date of issuance under Canadian securities legislation.
- Timeline Context: This follows the first tranche, which closed on November 14, 2025, and the initial announcement on November 6, 2025.
More from Algernon Health Inc
Mar 23, 2026 · 15:15